- Home
- CDP vs CPRX Comparison
CDP vs CPRX Comparison
Compare CDP & CPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDP
- CPRX
- Stock Information
- Founded
- CDP 1988
- CPRX 2002
- Country
- CDP United States
- CPRX United States
- Employees
- CDP N/A
- CPRX N/A
- Industry
- CDP Real Estate Investment Trusts
- CPRX Biotechnology: Pharmaceutical Preparations
- Sector
- CDP Real Estate
- CPRX Health Care
- Exchange
- CDP Nasdaq
- CPRX Nasdaq
- Market Cap
- CDP 3.1B
- CPRX 2.6B
- IPO Year
- CDP N/A
- CPRX 2006
- Fundamental
- Price
- CDP $27.77
- CPRX $19.86
- Analyst Decision
- CDP Buy
- CPRX Strong Buy
- Analyst Count
- CDP 6
- CPRX 6
- Target Price
- CDP $33.50
- CPRX $32.83
- AVG Volume (30 Days)
- CDP 778.3K
- CPRX 1.4M
- Earning Date
- CDP 07-28-2025
- CPRX 08-06-2025
- Dividend Yield
- CDP 4.39%
- CPRX N/A
- EPS Growth
- CDP N/A
- CPRX 183.96
- EPS
- CDP 1.27
- CPRX 1.65
- Revenue
- CDP $751,457,000.00
- CPRX $558,499,000.00
- Revenue This Year
- CDP $2.98
- CPRX $16.37
- Revenue Next Year
- CDP $4.62
- CPRX $8.80
- P/E Ratio
- CDP $21.83
- CPRX $12.05
- Revenue Growth
- CDP 3.13
- CPRX 28.55
- 52 Week Low
- CDP $23.92
- CPRX $17.23
- 52 Week High
- CDP $34.22
- CPRX $26.58
- Technical
- Relative Strength Index (RSI)
- CDP 47.60
- CPRX 36.63
- Support Level
- CDP $26.91
- CPRX $19.15
- Resistance Level
- CDP $28.58
- CPRX $22.53
- Average True Range (ATR)
- CDP 0.55
- CPRX 0.74
- MACD
- CDP 0.02
- CPRX -0.04
- Stochastic Oscillator
- CDP 50.00
- CPRX 21.01
About CDP COPT Defense Properties of Beneficial Interest
COPT Defense Properties is a fully-integrated and self-managed real estate investment trust (REIT) focused on owning, operating and developing properties in locations proximate to, or sometimes containing, key U.S. Government (USG) defense installations and missions. Its tenants include the USG and their defense contractors, who are engaged in priority national security activities, and who generally require mission-critical and high security property enhancements. Its properties include 195 operating properties totaling approximately 22.4 million square feet comprised of 16.5 million square feet in 164 office properties and 5.9 million square feet in 31 single-tenant data center shells.
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).